Advertisement

Leadership

Curative recently landed over $150 million in series B funding. Now, the COVID-19 testing company-turned-insurer is expanding. Curative CEO Fred Turner told Becker’s about the company’s choice to move into the Mid-Atlantic region, starting with Maryland and Washington, D.C. “In…

Cost Plus Drugs co-founder Mark Cuban and Humana CEO Jim Rechtin said their companies are working together, Forbes reported Dec. 4. “We’re talking to CenterWell,” Mr. Cuban said during the Forbes Healthcare Summit. “I would say we are treating the…

In 2025, health plans put emerging tech to use, but also had to discover and utilize workarounds for government regulations from the current administration. For many payers, navigating the past year has helped them plan ahead for 2026. Becker’s connected with…

The data is clear: complexity in our healthcare system leads to poorer outcomes. A report by the Milken Institute found that only 12% of adults in the U.S. are considered to have high health literacy. This directly impacts people’s ability…

Advertisement

At the Fall 2025 Becker’s Payer Issues Roundtable, CareSource Senior Vice President Todd Carlson participated in a fireside chat on how the nonprofit payer is modernizing its technology infrastructure to deliver more personalized, efficient and scalable healthcare. In partnership with…

Emerging technologies like generative AI and predictive analytics will be a difference maker in terms of health plans operating more efficiently in the very near future. Becker’s connected with ten health plan leaders to learn what innovation they think will most…

Advertisement